1. Home
  2. SYM vs CRSP Comparison

SYM vs CRSP Comparison

Compare SYM & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Symbotic Inc.

SYM

Symbotic Inc.

HOLD

Current Price

$59.42

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.26

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYM
CRSP
Founded
2005
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SYM
CRSP
Price
$59.42
$56.26
Analyst Decision
Hold
Buy
Analyst Count
14
19
Target Price
$53.00
$71.50
AVG Volume (30 Days)
4.4M
1.9M
Earning Date
02-04-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,246,922,000.00
$38,337,000.00
Revenue This Year
$21.90
N/A
Revenue Next Year
$28.00
$723.84
P/E Ratio
N/A
N/A
Revenue Growth
25.65
N/A
52 Week Low
$16.32
$30.04
52 Week High
$87.88
$78.48

Technical Indicators

Market Signals
Indicator
SYM
CRSP
Relative Strength Index (RSI) 45.92 50.34
Support Level $55.85 $54.60
Resistance Level $63.89 $58.00
Average True Range (ATR) 5.18 2.91
MACD -0.76 0.26
Stochastic Oscillator 14.20 59.23

Price Performance

Historical Comparison
SYM
CRSP

About SYM Symbotic Inc.

Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys end-to-end technology solutions that dramatically improve supply chain operations. Th company also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: